ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag salary funding pcr products

hannah burrack entomology tobacco budworm caterpillar spotted wing Drosophila coronavirus pandemic covid-19
Amid the COVID-19 Pandemic, Some Scientists Bring the Bench Home
Emma Yasinski | May 13, 2020 | 5 min read
PCR moves into the laundry room, while insect colonies take up residence in the shower.
feluda cas9 fncas9 covid-19 sars-cov-2 diagnostics coronavirus pandemic india
Assay for Sickle Cell Anemia Is Repurposed to Diagnose COVID-19
G.B.S.N.P. Varma | Nov 18, 2020 | 5 min read
A CRISPR-based, paper-strip test developed by Indian researchers performs as well as real-time PCR in identifying the presence of SARS-CoV-2 and returns results within an hour.
Activists protest. Political riot sign banners, people holding protests placards and manifestation banner. Jobs activist strike, vegetarians meeting or feminist demonstration vector illustration
Unionization Efforts Pick Up Across US Universities
Catherine Offord, Andy Carstens, and Amanda Heidt | Sep 1, 2022 | 10 min read
Members of newly certified workers’ organizations at campuses across the US speak about how they achieved official recognition and what they’re planning for the years ahead.
Top 10 Innovations 2014
The Scientist | Dec 1, 2014 | 10+ min read
The list of the year’s best new products contains both perennial winners and innovative newcomers.
2020 Top 10 Innovations
The Scientist | Dec 1, 2020 | 10+ min read
From a rapid molecular test for COVID-19 to tools that can characterize the antibodies produced in the plasma of patients recovering from the disease, this year’s winners reflect the research community’s shared focus in a challenging year.
Genome Investigator Craig Venter Reflects On Turbulent Past And Future Ambitions
Karen Young Kreeger | Jul 23, 1995 | 8 min read
And Future Ambitions Editor's Note: For the past four years, former National Institutes of Health researcher J. Craig Venter has been a major figure in the turbulent debates and scientific discoveries surrounding the study of genes and genomes. Events heated up in 1991, when NIH attempted to patent gene fragments, which were isolated using Venter's expressed sequence tag (EST)/complementary DNA (cDNA) approach for discovering human genes (M.A. Adams et al., Science, 252:1651-6, 1991). NIH's mo
U.S. Could Benefit Greatly From Aiding Ex-Soviet Scientists
Richard Eisner | Mar 29, 1992 | 8 min read
These individuals, and others like them, worked on classified military research. None favors nuclear proliferation, but each has the potential to make substantive scientific and engineering contributions to weapons programs in what have come to be known as the "rogue nations" of the world--Iraq, for example. But they also have the potential to contribute to the United States gross national product. Fortunately, they are in the U.S. at the moment, seeking productive employment in the research
Save $29,000 this year
Melissa Lee Phillips | Jan 1, 2006 | 9 min read
FEATURESave in the Lab By Melissa Lee PhillipsAs a graduate student and postdoc, Doug Juers never hadto worry about money; he worked in Howard HughesMedical Institute-funded labs that were flush with cash.Since recently joining the departments of physics andbiophysics, biochemistry, and molecular biology at Whitman Collegein Walla Walla, Wash., however, Juers has had to learn
Bioterrorism Research: New Money, New Anxieties
John Dudley Miller | Apr 6, 2003 | 8 min read
Ned Shaw US scientists have reason to feel both heady and scared. The federal government recently released unprecedented billions of dollars to fund bioterrorism research. Yet, the merits of this sudden shift in focus are being debated, and some worry that the money will be squandered or wasted. "I have been really very upset by the focus on bioterrorism," says Stanley Falkow, professor of microbiology and immunology and of medicine at Stanford University. "Everybody's talking about it, but th
Pets Vs. Pen Animals
Kathryn Brown | Aug 18, 1996 | 8 min read
Biotechnology Boom Molecular biologists find niche as new technologies are adapted to the animal health market. While the biotech boom resounds in human health research, the technology has made less of a roar in the animal health field. Uncertainty over product costs and regulatory approval has left some animal health companies hesitant to embrace biotechnology. But this situation could be changing. A growing number of vaccines for cats, dogs, and fish are based on recombinant DNA techniques.

Run a Search

ADVERTISEMENT